ClinicalTrials.govpublic full text
Bevacizumab and Lomustine for Recurrent GBM
glioblastoma multiforme, cognition disorders, disability evaluation, adult glioblastoma, recurrent adult brain tumor, functional defects, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.